- Home
- Media Center
- Press releases
- Innovative Medicine
Innovative Medicine
Latest Data for Type 2 Diabetes Treatment INVOKANA™ (canagliflozin) to be Presented at American Diabetes Association Annual Meeting
Late-Breaking Phase 3 Results and Health Economics Data are Among 17 Accepted Presentations
STELARA® Phase 3 Study Published In The Lancet Reports One Year Efficacy And Safety In Treatment Of Active Psoriatic Arthritis
Data Show Interleukin-12/23 Inhibitor STELARA Improved Joint, Soft Tissue and Skin Components of Psoriatic Arthritis
Five-Year SIMPONI Data Reported In Treatment Of Signs And Symptoms Of Moderately To Severely Active Rheumatoid Arthritis
Data from Three Pivotal Phase 3 Trials Presented at 2013 EULAR Annual Congres
Janssen, Johnson & Johnson Innovation, Announce Collaboration With Belgian Scientists To Pursue New Research In Neurodegenerative Diseases
Effort Advances Company’s Global Healthy Minds Initiative
Survey of Participants from Landmark GRACE Trial Provides Patients’ Perspectives from an HIV Clinical Study
Most Survey Participants Would Recommend Joining a Study to Others